Shock, Anaphylactoid Reaction: Since shock and anaphylactoid reactions may occur, patients should be carefully observed. If symptoms eg, erythema, rash, dyspnoea, decreased blood pressure and eyelid oedema, etc are observed, administration should be discontinued and appropriate measure should be taken.
Others: If the following adverse reactions are observed, appropriate measures eg, discontinuing administration should be taken.
Hypersensitivity: Occasionally: Blepharitis (eyelid redness/oedema, etc), eyelid dermatitis, itching. Rare: Urticaria. Unknown Incidence: Rash.
Ophthalmic: Occasionally: Irritation, corneal lesion eg, superficial diffuse keratitis. Rare: Conjunctivitis (conjunctival injection/oedema, etc), eye pain.
View ADR Monitoring Form